Skip to main content
. Author manuscript; available in PMC: 2014 Oct 13.
Published in final edited form as: Clin Cancer Res. 2008 Nov 15;14(22):7196–7204. doi: 10.1158/1078-0432.CCR-07-5051

Fig. 5.

Fig. 5

EPO reduces PARP cleavage in ETV6/RUNX1-positive leukemias exposed to prednisone. PARP cleavage was determined byWestern blot analysis in AT-2, REH, Nalm6, and SEM cells after exposure to prednisone and EPO for the indicated times. Glyceraldehyde 3-phosphate dehydrogenase was used as loading control. PARP cleavage was normalized to glyceraldehyde 3-phosphate dehydrogenase and values are shown as n-fold expression at the bottom of the graph.